Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2014-11-21

FDA Approved: CREON — Supplemental Application (AbbVie Inc.)

View source ↗

Summary

FDA approved a supplemental application for CREON (pancrelipase) from AbbVie, updating the labeling to reflect approved uses for exocrine pancreatic insufficien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Creon (pancrelipase)

Snippet

SUPPL AP for CREON (PANCRELIPASE)